Human colorectal pre-cancer atlas identifies distinct molecular programs underlying two major subclasses of pre-malignant tumors

Bob Chen(Vanderbilt University), Ken S. Lau(Vanderbilt University), Cody N. Heiser(Vanderbilt University), Qiuyin Cai(Vanderbilt University), Frank Revetta(Vanderbilt University Medical Center), James R. Goldenring(Vanderbilt University), Xiangzhu Zhu(Vanderbilt University), Jeffrey L. Franklin(San Francisco VA Medical Center), Nicholas O. Markham(VA Tennessee Valley Healthcare System), Lynne D. Berry(Vanderbilt University Medical Center), Marisol Ramirez‐Solano(Vanderbilt University Medical Center), Joseph T. Roland(Vanderbilt University Medical Center), Austin N. Southard-Smith(Vanderbilt University), Quanhu Sheng(Cancer Research And Biostatistics), Yuan Zhou(Vanderbilt University Medical Center), Robert J. Coffey(Vanderbilt University), Alan J. Simmons(Vanderbilt University), Eliot T. McKinley(Vanderbilt University), Won Jae Huh(Vanderbilt University Medical Center), Martha J. Shrubsole(Vanderbilt University), Julia L. Drewes(Johns Hopkins University), Yanwen Xu(Vanderbilt University), Simon Vandekar(Vanderbilt University Medical Center), Timothy Su(Vanderbilt University), M. Kay Washington(Vanderbilt University Medical Center), Qi Liu(Fudan University Shanghai Cancer Center), Wei Zheng(Vanderbilt University), Cynthia L. Sears
bioRxiv (Cold Spring Harbor Laboratory)
January 13, 2021
Cited by 3


Related Papers